©istock.com/Andrea Obzerova
Interdisciplinary CompetenceMolecular Diagnostics
Know how in the analysis of genetic material.
For the benefit of patients.

IllnessWT1 disorder, DD Wilms tumor predisposition + Steroid-resistant nephrotic syndrome

Summary

Short information

Comprehensive differential diagnostic panel for WT1 disorder [DD Wilms tumor predisposition + Steroid-resistant nephrotic syndrome] containing 1 guideline-curated gene, furthermore 3 core candidate genes and altogether 17 curated genes according to the clinical signs

ID
WP0040
Number of loci
Locus typeCount
Gen 16
Accredited laboratory test
Examined sequence length
9,4 kb (Core-/Core-canditate-Genes)
61,1 kb (Extended panel: incl. additional genes)
Analysis Duration
on request
Test material
  • EDTA-anticoagulated blood (3-5 ml)
Diagnostic indications

NGS +

 

Loci

Gen

NameExon Length (bp)OMIM-GReferenz-Seq.Heredity
NPHS13726NM_004646.4AR
NPHS21152NM_014625.4AR
SMARCAL12865NM_001127207.2AR
WT11569NM_024426.6AD, SMu
BLM4254NM_000057.4AR
BRCA210257NM_000059.4AD, SMu
BUB1B3153NM_001211.6AR
COL4A35013NM_000091.5AD, AR
COL4A45073NM_000092.5AD, AR
COL4A55058NM_000495.5XL
CTR93547NM_014633.5AD
DICER15769NM_177438.3AD, Sus
DIS3L22658NM_152383.5AD
GPC31743NM_004484.4XLR, Sus, SMu
POU6F21968NM_001166018.2AD, Sus
REST3294NM_005612.5AD, Sus

Informations about the disease

Synonyms
  • Wilms tumor, type 1 (WT1)
  • Denys-Drash syndrome (WT1)
  • Frasier syndrome (WT1)
  • Meacham syndrome (WT1)
  • Mesothelioma, somatic (WT1)
  • Nephrotic syndrome, type 4 (WT1)
  • Allelic: Alport syndrome 1, XL (COL4A5)
  • Allelic: Alport syndrome 2, AR (COL4A3, COL4A4)
  • Allelic: Alport syndrome 3, AD (COL4A3)
  • Allelic: Bone marrow failure syndrome 5 (TP53)
  • Allelic: Breast cancer, somatic (PIK3CA)
  • Allelic: Breast cancer, somatic (TP53)
  • Allelic: Breast cancer, susceptibility to (PALB2)
  • Allelic: Breast-ovarian cancer, familial, 2 (BRCA2)
  • Allelic: CLAPO syndrome, somatic (PIK3CA)
  • Allelic: CLOVE syndrome, somatic (PIL3CA)
  • Allelic: Deafness, AD 27 (REST)
  • Allelic: Fanconi anemia, complementation group D1 (BRCA2)
  • Allelic: Fanconi anemia, complementation group N (PALB2)
  • Allelic: Fibromatosis, gingival, 5 (REST)
  • Allelic: Goiter, multinodular 1, with/-out Sertoli-Leydig cell tumors (DICER1)
  • Allelic: Hyperparathyroidism, familial primary (CDC73)
  • Allelic: Hyperparathyroidism-jaw tumor syndrome (CDC73)
  • Allelic: Nasopharyngeal carcinoma, somatic (TP53)
  • Allelic: Parathyroid adenoma with cystic changes (CDC73)
  • Allelic: Parathyroid carcinoma (CDC73)
  • Allelic: Pleuropulmonary blastoma (DICER1)
  • Allelic: Rhabdomyosarcoma, embryonal, 2 (DICER1)
  • Bloom syndrome (BLM)
  • Colorectal cancer, somatic (BUB1B)
  • Colorectal cancer, somatic (PIK3CA)
  • Cowden syndrome 5 (PIK3CA)
  • Familial Wilms tumor [panelapp] (CTR9)
  • Focal segmental glomerulosclerosis 10 (LMX1B)
  • GLOW syndrome, somatic mosaic [Global devel. delay, Lung cysts, Overgrowth, WT] (DICER1)
  • Hematuria, benign familial (COL4A3, COL4A4)
  • Hepatocellular carcinoma, somatic (TP53)
  • Keipert syndrome [craniofacial + digital abnormalities, learning difficulties] (GPC4)
  • Li-Fraumeni syndrome (TP53)
  • Mosaic variegated aneuploidy syndrome 1 (BUB1B)
  • Mulibrey nanism (TRIM37)
  • Nail-patella syndrome (LMX1B)
  • Nephrotic syndrome, type 1 (NPHS1)
  • Nephrotic syndrome, type 2 (NPHS2)
  • Ovarian cancer, somatic (PIK3CA)
  • Pancreatic cancer, somatic (TP53)
  • Pancreatic cancer, susceptibility to, 3 (PALB2)
  • Perlman syndrome [similar to Beckwith-Wiedemann syndrome] (DIS3L2)
  • Schimke immunoosseous dysplasia (SMARCAL1)
  • Simpson-Golabi-Behmel syndrome, type 1 [overgrowth, face, cong. heart defects + add.] (GPC3)
  • Wilms tumor (BRCA2)
  • Wilms tumor 6, susceptibility to (REST)
  • Wilms tumor susceptibility-5 (POU6F2)
  • Wilms tumor, somatic (GPC3)
Heredity, heredity patterns etc.
  • AD
  • AR
  • SMu
  • Sus
  • XL
  • XLR
OMIM-Ps
  • Multiple OMIM-Ps
ICD10 Code

Bioinformatics and clinical interpretation

No text defined